Kalbe Farma Tbk vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp129 (market cap 170.67B, 1.26M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 193.4× Zyrexindo Mandiri Buana Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (98.44M versus 1.26M). Which is the better fit depends on your goals.
| KLBF | ZYRX | |
|---|---|---|
Market Cap | 33T | 170.67B |
Volume | 98.44M | 1.26M |
Lot | 984.38K | 12.6K |
Turnover | 70.64B | 162.38M |
Average Price | 717.58 | 128.9 |
Value | 70.64B | 162.38M |
Indicative Equilibrium Price | 720 | 129 |
Indicative Equilibrium Volume | 43.62K | 233 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Read more on ZYRX →